Dr. Josef Penninger is from the University of British Columbia and the Institute for Molecular Biotechnology of the Austrian Academy of Sciences in Vienna, Austria. He was previously on the podcast to talk about his research developing human blood vessel organoids. Dr. Penninger’s team has identified a trial drug that can significantly block early stages of COVID-19 in human blood vessel and kidney organoids.
Read More
Guest Dr. Robert Hancock is a Professor of Microbiology and Immunology, UBC, and a Canada Research Chair in Health and Genomics. Bob has published more than 660 papers and reviews, and has 50 patents awarded. The…
Read More
Guest Dr. Hongjun Song is a Director of the Stem Cell Program at John Hopkins University. The research in the Song laboratory focuses on understanding mechanisms regulating neural stem cells and neurogenesis in the mammalian…
Read More
Guest Dr. Eggan is a Professor in the Department of Stem Cell and Regenerative Biology, Harvard University. On this show he joins us, along with a post-doctoral fellow from his lab, Dr. Michael Wells, to…
Read More
Guest Dr. Jen Adair, assistant member of the clinical research division at the Fred Hutch Cancer Research Center, and Assistant Professor of Medical Oncology at the University of Washington School of Medicine. Adair’s group investigates…
Read More